Japan Respiratory Disease Market Outlook to 2013 Emerging Opportunities

2013-01-24

This report presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies Reviews features and operating characteristics of major analyzers used for microbiology testing; Profiles key suppliers and potential market entrants developing innovative technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Request your sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=68983

Buy Your Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=68983

Table Of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers

C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares

Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments

List of Tables

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests Japan
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Testing Market Diagnostics Sales Forecast by Major Supplier Japan
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mononucleosis Testing Market Diagnostics Sales by Major Supplier Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mycoplasma Testing Market Diagnostics Sales by Major Supplier Japan
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Pneumonia Testing Market Diagnostics Sales by Major Supplier Japan
RSV Test Volume and Diagnostics Sales Forecast by Market Segment Japan
RSV Testing Market Diagnostics Sales by Major Supplier Japan
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Tuberculosis Testing Market Diagnostics Sales by Major Supplier

Filed in: Diagnostics, Medical Device
More Reports
Title Price Buy Now

Global Blood Stream Infection Testing Market 2016-2020

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting. This analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the repo......
$2500

Global Professional Diagnostics Market 2016-2020

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years. This analyst forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020. Covered in this report This report covers the present scenario and the......
$2500

Global Point-of-Care Coagulation Testing Market 2016-2020

Coagulation testing measures the ability of blood to form a clot. Clotting is the process of the blood converting from a liquid into a gel form. Coagulation tests are carried out to detect clotting disorders such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, PT, platelet count, TT, and bleeding time. The analysts forecast global point-of-care coagulation testing market to grow at a CAGR of 6.53% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global point-of-care coagulation testing market for 2016-2020. A 360-degree view of the market, based on products, application, and technology segments, has been considered for ma......
$2500

Global Enteric Disease Testing Market 2016-2020

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests. The analysts forecast global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calcula......
$2500

Global Gonorrhea Diagnostics Market 2016-2020

Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US. The analysts forecast global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global gonorrhea diagn......
$2500

Global Transplant Diagnostics Market 2016-2020

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. The analysts forecast global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global......
$2500

IVD Market in Europe 2016-2020

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples. The analysts forecast IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the mar......
$2500

Global Rapid Diagnostics Market 2016-2020

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can b......
$2500

Global Molecular Diagnostics Market 2016-2020

The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market. The analysts forecast global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects o......
$2500

Global Tissue Diagnostics Market 2016-2020

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (I......
$2500